List of Aurinia Pharmaceuticals patents | 8 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11622991 Protocol for treatment of lupus nephritis	Patent 11622991 was granted and assigned to Aurinia Pharmaceuticals on April, 2023 by the United States Patent and Trademark Office.	Aurinia Pharmaceuticals	Aurinia Pharmaceuticals	United States Patent and Trademark Office	11622991	April 11, 2023
‌ US Patent 10265375 Ophthalmic compositions	Patent 10265375 was granted and assigned to Aurinia Pharmaceuticals on April, 2019 by the United States Patent and Trademark Office.	Aurinia Pharmaceuticals	Aurinia Pharmaceuticals	United States Patent and Trademark Office	10265375	April 23, 2019
‌ US Patent 10472394 Cyclosporine analogue mixtures and their use as immunomodulating agents	Patent 10472394 was granted and assigned to Aurinia Pharmaceuticals on November, 2019 by the United States Patent and Trademark Office.	Aurinia Pharmaceuticals	Aurinia Pharmaceuticals	United States Patent and Trademark Office	10472394	November 12, 2019
‌ US Patent 10286036 Protocol for treatment of lupus nephritis	Patent 10286036 was granted and assigned to Aurinia Pharmaceuticals on May, 2019 by the United States Patent and Trademark Office.	Aurinia Pharmaceuticals	Aurinia Pharmaceuticals	United States Patent and Trademark Office	10286036	May 14, 2019
‌ US Patent 9017725 Topical drug delivery systems for ophthalmic use	Patent 9017725 was granted and assigned to Aurinia Pharmaceuticals on April, 2015 by the United States Patent and Trademark Office.		Aurinia Pharmaceuticals	United States Patent and Trademark Office	9017725	April 28, 2015
‌ US Patent 10973871 Ophthalmic compositions	Patent 10973871 was granted and assigned to Aurinia Pharmaceuticals on April, 2021 by the United States Patent and Trademark Office.	Aurinia Pharmaceuticals	Aurinia Pharmaceuticals	United States Patent and Trademark Office	10973871	April 13, 2021
‌ US Patent RE48226 Cyclosporine analogue mixtures and their use as immunomodulating agents		Aurinia Pharmaceuticals	Aurinia Pharmaceuticals	United States Patent and Trademark Office	RE48226	September 29, 2020
‌ US Patent 9765119 Cyclosporine analogue mixtures and their use as immunomodulating agents	Patent 9765119 was granted and assigned to Aurinia Pharmaceuticals on September, 2017 by the United States Patent and Trademark Office.	Aurinia Pharmaceuticals	Aurinia Pharmaceuticals	United States Patent and Trademark Office	9765119	September 19, 2017